Irinotecan Pharmacogenetics in Japanese Cancer Patients: Roles of UGT1A1*6 and *28
Author:
Affiliation:
1. Division of Functional Biochemistry and Genomics, National Institute of Health Sciences
2. Medical Oncology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology
Link
https://www.jstage.jst.go.jp/article/yakushi/128/4/128_4_575/_pdf
Reference42 articles.
1. 1) Slatter J. G., Su P., Sams J. P., Schaaf L. J., Wienkers L. C., Drug Metab. Dispos., 25, 1157-1164 (1997).
2. 2) Iyer L., King C. D., Whitington P. F., Green M. D., Roy S. K., Tephly T. R., Coffman B. L., Ratain M. J., J. Clin. Invest., 15, 847-854 (1998).
3. 3) Haaz M. C., Rivory L., Riche C., Vernillet L., Robert J., Cancer Res., 58, 468-472 (1998).
4. 4) Sparreboom A., Danesi R., Ando Y., Chan J., Figg W. D., Drug Resist. Updat., 6, 71-84 (2003).
5. 5) Nozawa T., Minami H., Sugiura S., Tsuji A., Tamai I., Drug Metab. Dispos., 33, 434-439 (2005).
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice;Xenobiotica;2020-04-22
2. High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy;Medical Oncology;2019-06-03
3. Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome;Cancer Chemotherapy and Pharmacology;2018-12-18
4. Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer;Cancer Chemotherapy and Pharmacology;2018-10-30
5. Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population;Drug Metabolism and Pharmacokinetics;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3